HUMHUMANA INCvs its industry peers
A metric-by-metric comparison of HUMANA INC against Health Care Select Sector SPDR Fund holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HUM본 종목 | $45.0B#16 | 40.0x#12 | 2.4x#3 | 0.3x#2 | 10.1%#4 | -1.6%#11 | 2.1%#15 | 6.4%#14 | 8.1%#12 | — | 46.7%#4 | 1.0%#11 |
| LLY | $1.08T#1 | 38.3x#11 | 31.7x#15 | 16.5x#16 | 44.7%#1 | 94.9%#4 | 40.2%#1 | 60.9%#3 | 26.3%#2 | — | 52.0%#3 | 0.5%#13 |
| JNJ | $640.3B#2 | 30.8x#7 | 7.5x#9 | 6.8x#12 | 6.0%#9 | 90.6%#5 | 22.9%#8 | 31.5%#7 | 16.1%#7 | 6#2 | 55.5%#2 | 1.9%#10 |
| ABBV | $465.3B#3 | 74.4x#14 | — | 7.6x#13 | 8.6%#7 | -1.2%#10 | 24.6%#7 | — | 18.6%#6 | — | 21.2%#11 | 2.5%#4 |
| UNH | $338.8B#5 | 24.3x#3 | 10.3x#12 | 0.8x#3 | 11.8%#3 | -16.3%#14 | 4.2%#14 | 36.5%#5 | 21.3%#5 | — | 13.2%#14 | 2.3%#6 |
| MRK | $367.2B#4 | 119.1x#15 | 8.8x#11 | 5.6x#8 | 1.3%#14 | 6.6%#8 | 34.2%#3 | 43.5%#4 | 21.6%#4 | — | 89.2%#1 | 2.2%#8 |
| AMGN | $217.5B#7 | 25.0x#4 | 18.6x#14 | 5.9x#9 | 10.0%#5 | 88.5%#6 | 24.7%#6 | 66.0%#2 | 15.1%#8 | — | 43.9%#6 | 2.4%#5 |
| TMO | $241.8B#6 | 35.2x#8 | 4.6x#6 | 5.4x#7 | 3.9%#11 | 6.0%#9 | 17.4%#12 | 12.8%#10 | 10.1%#10 | — | 38.1%#7 | 0.3%#14 |
| ABT | $179.8B#9 | 28.9x#5 | 3.5x#5 | 4.1x#6 | 5.7%#10 | -51.3%#15 | 18.2%#11 | 12.5%#11 | 8.3%#11 | — | -22.7%#16 | 2.3%#7 |
| GILD | $185.2B#8 | — | 15.7x#13 | 6.3x#11 | 2.4%#13 | 1672.9%#1 | 34.0%#4 | 71.9%#1 | 26.7%#1 | — | 35.7%#8 | 2.2%#9 |
| ISRG | $141.4B#12 | 45.9x#13 | 7.8x#10 | 14.1x#15 | 20.5%#2 | 23.0%#7 | 29.3%#5 | 15.7%#9 | — | — | -9.9%#15 | — |
| PFE | $157.4B#10 | 36.3x#9 | 1.8x#2 | 2.5x#4 | -1.6%#16 | -3.2%#12 | 16.3%#13 | 9.1%#12 | 6.9%#13 | — | 22.0%#10 | 6.2%#1 |
| CVS | $112.3B#15 | 23.2x#2 | 1.4x#1 | 0.3x#1 | 7.8%#8 | -61.7%#16 | 1.2%#16 | 2.2%#15 | 2.9%#15 | 6#2 | 20.4%#12 | 3.0%#3 |
| VRTX | $129.2B#13 | 29.7x#6 | 6.4x#8 | 10.8x#14 | 8.9%#6 | 838.1%#2 | 34.8%#2 | 19.5%#8 | 25.0%#3 | — | 33.1%#9 | — |
| DHR | $151.2B#11 | 38.2x#10 | 2.9x#4 | 6.2x#10 | 2.9%#12 | -7.3%#13 | 19.1%#10 | 6.9%#13 | 5.4%#14 | 5#4 | 13.7%#13 | 0.6%#12 |
| BMY | $127.5B#14 | 13.8x#1 | 5.7x#7 | 2.6x#5 | -0.2%#15 | 178.8%#3 | 21.8%#9 | 31.6%#6 | 14.0%#9 | 7#1 | 44.3%#5 | 4.0%#2 |
Peer set: top holdings of XLV (Health Care Select Sector SPDR Fund), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-22.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice